OraQuick Rapid Diagnostic Tests

OraQuick has become a trusted name in point-of-care screening precisely because it removes the biggest barrier to testing: waiting. These lateral-flow tests deliver visual results in about 20 to 40 minutes, no lab courier or analyzer required — which makes them a practical fit for clinics, outreach programs, correctional health, harm-reduction sites, and community screening events where a same-visit result changes what happens next.

The core of the line is the OraQuick Advance Rapid HIV-1/2 Test Kit (1001-0079), an antibody screen that gives clinicians and patients an answer in a single sitting. Alongside it, the OraQuick HCV Rapid Antibody Test (1001-0181 and 1001-0180) screens for hepatitis C from a whole-blood sample using the same familiar device format and visual read — valuable given how often HCV goes undiagnosed until liver damage is advanced. Early identification is what makes these tests worth stocking: a reactive screen routes someone toward confirmatory testing and treatment far sooner than symptom-driven care would.

We also carry the Orasure Q.E.D. Drugs of Abuse Test (31150B), a 10-test saliva-based kit with collection swab and instructions included. Saliva collection is non-invasive and observed, which appeals to workplace, treatment-monitoring, and clinical settings that want to avoid the logistics and privacy concerns of urine collection.

When ordering, note the sample type each kit requires — whole blood for the HIV and HCV screens, oral fluid for the Q.E.D. drug panel — and confirm your CLIA-waived status matches the setting where testing will occur. All are qualitative, visually read screening tests intended to be followed by confirmatory testing when reactive.

OraQuick and Orasure diagnostics sit within our broader range of Diagnostics and point-of-care testing supplies.